22nd Annual University of Chicago Developmental Therapeutics Symposium

Chicago, IL US
April 28, 2017
The goals of this activity are to help consortium members assimilate requirements of new studies, review synthesized data from completed studies, discuss the novel investigational agents available from the National Cancer Institute and other sponsors, describe the rational for and results of studies that include new targeted agents for the treatment of patients with advanced and rare disease. This knowledge will enable them to make new treatments available to cancer patients, provide support for current and future oncology clinical trials, and become stronger leaders in the area of oncology research. This program will convey information on how to implement precision medicine on Oncology, leading to better outcomes for patients suffering from cancer. 

Target Audience

This activity has been designed for physicians and other health care professionals currently involved in the diagnosis, screening, and treatment of cancer patients.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • State the effects of the use of novel experimental agents from the National Cancer Institute and other sponsors;
  • Cite the relevant pharmacology and biologic effects of novel anti-cancer agents through the use of blood and tissue samples as well as standard and novel imaging approaches;
  • Assess patient suitability for participation in available and upcoming cancer clinical trials and projects;
  • Discuss advances in the use of chemotherapy and other targeted therapies for cancer;
  • Describe the rational for and results of studies that include new targeted agents for the treatment of patients with advanced and rare disease;
  • Summarize how updated regulatory and data operations information can support clinical trial conduct as administrative systems evolve.
Additional information
ABMS Core Competencies: 
Medical Knowledge
Systems-based Practice
For more information, please contact:
CME Coordinator Contact Name: 
Mary Sherrell
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
773-702-9856
Summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Participation
Event starts: 
04/28/2017 - 8:00am
Event ends: 
04/28/2017 - 2:30pm
Activity opens: 
04/28/2017
Activity expires: 
10/28/2017
Gleacher Center
450 N Cityfront Plaza
Chicago, IL 60611
United States
  ACTIVITY DIRECTOR
  Walter Stadler, MD
  Professor, Section Chief, Hematology/Oncology
 
 

  KEYNOTE SPEAKER 
  Suzanne Conzen, MD 
  Professor of Medicine


 

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Registration: Closed to the public.
 
Claiming Credit: Enter the access code to unlock the credit claiming process.
Please login or create an account to proceed.